Edward Fang MD

Chief Medical Officer Clinical Development

PO Box 51173Irvine, CA 92619

Dr. Fang is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fang's full profile Already have an account?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1996 - 1999
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1996 - 1997
David Geffen School of Medicine at UCLAClass of 1996, MD
Stanford UniversityBA

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1998 - 2027

Publications & Presentations

PubMed

3 citations
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens.
Jürgen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee
Antimicrobial Agents and Chemotherapy. 2024-04-03
14 citations
Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infect...
Alejandro Ortiz-Covarrubias, Edward Fang, Philippe Prokocimer, Shawn Flanagan, Xu Zhu
The Brazilian Journal of Infectious Diseases. 2016-03-01
125 citations
Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections
Andrew F. Shorr, Thomas P. Lodise, G. Ralph Corey, Carisa De Anda, Edward Fang
Antimicrobial Agents and Chemotherapy. 2015-02-01

Press Mentions

Pet Wellness Center in Murrieta Offers After-Hours Emergency ServicesApril 2nd, 2021
MicuRx Pharmaceuticals Reports Positive Top-Line Results from a US Phase 2 ABSSSI Clinical Trial of Novel Antibiotic Contezolid AcefosamilSeptember 9th, 2019